Shorr, A. F., McDonald, M. L., Tector, A. J., Downey, F. X., Kress, D. C., Aronson, S., & Anderson, A. J. (2005). HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB). In Critical Care Medicine (Vol. 33, pp. A79–A79). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00003246-200512002-00282

Shorr, A. F., M. L. McDonald, A. J. Tector, F. X. Downey, D. C. Kress, S. Aronson, and A. J. Anderson. “HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB).” In Critical Care Medicine, 33:A79–A79. Ovid Technologies (Wolters Kluwer Health), 2005. https://doi.org/10.1097/00003246-200512002-00282.

Shorr AF, McDonald ML, Tector AJ, Downey FX, Kress DC, Aronson S, et al. HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB). In: Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2005. p. A79–A79.

Shorr, A. F., et al. “HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB).” Critical Care Medicine, vol. 33, Ovid Technologies (Wolters Kluwer Health), 2005, pp. A79–A79. Crossref, doi:10.1097/00003246-200512002-00282.

Shorr AF, McDonald ML, Tector AJ, Downey FX, Kress DC, Aronson S, Anderson AJ. HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB). Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2005. p. A79–A79.